TRxADE HEALTH Inc - MEDS Net earnings per share (EPS TTM)

TRxADE HEALTH, Inc. (MEDS) connects distributors and independent pharmacies through shared digital tools to optimize procurement. The company attracts talent via a flexible remote format and its status as a niche monopolist in the pharmaceutical IT sector. After evaluating the rolling annual net income per share growth on GURU.Markets, we find 62.00, which describes the current status of the metric during the business transition to AI platforms for personalized nutrition.
TRxADE HEALTH, Inc. - analytical breakdowns and key metrics (MEDS)

Digitalization efficiency for pharmacies is critical for TRxADE HEALTH, Inc. (MEDS) amid intense pressure from major distributors. This indicator measures the growth rate of net income per share over the last twelve months relative to the same period last year. The metric assesses the business's ability to scale profitability while overcoming the low margins of intermediary operations. Positive momentum confirms the company's resilience to operating expenses. By analyzing the year-over-year change in EPS (TTM), investors can determine the real efficiency of capital management.